Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Dr.Lal Pathlabs has informed that the details of proposed schedule of Analyst/Institutional Investor meeting(s) as on 24 November 2020 with Ambit's Healthcare Conclave. Dates of the aforesaid meeting/Cal/ are subject to change due to exigencies on the part of Investor/Company. No Unpublished Price Sensitive Information will be shared during the meetings. Further details of the same as enclose.
The above information is a part of company’s filings submitted to BSE.
